Skip to search formSkip to main contentSkip to account menu

prizidilol

Known as: 3(2H)-Pyridazinone, 6-(2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-, Hydrazone, 3(2H)-Pyridazinone, 6-(2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-, hydrazone, dihydrochloride, (+-)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The metal complexing properties of two antihypertensive drugs, hydralazine (1-hydrazinophthalazine) and prizidilol (a… 
Highly Cited
1987
Highly Cited
1987
Summary: Carvedilol is a new β-receptor blocking and vasodilating drug that is presently undergoing clinical trials in… 
Highly Cited
1983
Highly Cited
1983
While it is well established that the acute haemodynamic effects of the beta blockers used in antihypertensive therapy vary… 
1983
1983
1 The effects of a single oral dose of 600 mg of prizidilol on renal function were studied 5 to 6 h after dosing in six normal… 
1983
1983
Combinations of beta-adrenoceptor blockers and vasodilators have proved highly useful in antihypertensive therapy. Studies of the… 
1982
1982
We studied the long-term hemodynamic effect of prizidilol (a precapillary vasodilator and β-adrenoceptor blocker) in 14 men aged… 
1982
1982
Summary Several new β-adrenoceptor antagonists (sulfinalol, MK 761, and prizidilol) have been reported to possess direct… 
1981
1981
Single oral doses of 1.5, 3.0, 4.5, and 6.0 mg/kg prizidilol HCl, an antihypertensive with vasodilator and β‐adrenoceptor… 
1981
1981
1. The antihypertensive effect of 4 weeks' treatment with prizidilol (SKF 92657) (mean dosage 520 mg once or twice daily) was… 
1981
1981
1. Prizidilol (SKF 92 657), a new antihypertensive drug with combined precapillary vasodilator and non-selective β-adrenoceptor…